Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

for (Select 12716265)

1.

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.

Stocchi F, Nordera G, Jokinen RH, Lepola UM, Hewett K, Bryson H, Iyengar MK; Paroxetine Generalized Anxiety Disorder Study Team.

J Clin Psychiatry. 2003 Mar;64(3):250-8.

PMID:
12716265
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
4.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
5.

Paroxetine: an update of its use in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

Drugs. 2002;62(4):655-703. Review. Erratum in: Drugs 2002;62(10):1461.

PMID:
11893234
6.

Generalized anxiety disorder in primary care: emerging issues in management and treatment.

Culpepper L.

J Clin Psychiatry. 2002;63 Suppl 8:35-42. Review.

PMID:
12044106
7.

Focus on paroxetine.

Green B.

Curr Med Res Opin. 2003;19(1):13-21. Review.

PMID:
12661775
8.

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

Bourin M.

Hum Psychopharmacol. 2003 Apr;18(3):185-90. Review.

PMID:
12672169
9.

Treatment of generalized anxiety disorder.

Gorman JM.

J Clin Psychiatry. 2002;63 Suppl 8:17-23. Review.

PMID:
12044104
10.

Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.

Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.

J Clin Psychiatry. 1990 Sep;51 Suppl:31-9. Review.

PMID:
2211564
11.

Pharmacotherapy of generalized anxiety disorder.

Rickels K, Rynn M.

J Clin Psychiatry. 2002;63 Suppl 14:9-16. Review.

PMID:
12562113
12.

Long-term treatment strategies in anxiety disorders.

Allgulander C, Hirschfeld RM, Nutt DJ.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:79-92. Review.

PMID:
12490824
13.

Treating generalized anxiety disorder.

Gorman JM.

J Clin Psychiatry. 2003;64 Suppl 2:24-9. Review.

PMID:
12625796
14.

Pharmacological treatment of generalized anxiety disorder.

Baldwin DS, Ajel KI, Garner M.

Curr Top Behav Neurosci. 2010;2:453-67. Review.

PMID:
21309121
15.

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Gao K, Sheehan DV, Calabrese JR.

Expert Rev Neurother. 2009 Aug;9(8):1147-58. doi: 10.1586/ern.09.37. Review.

16.

[Pharmacotherapy of generalized anxiety disorder: state of the art].

Zullino DF, Hättenschwiler J, Mattia M, Stankovic M, Khazaal Y, Borgeat F.

Praxis (Bern 1994). 2003 Oct 15;92(42):1775-9. Review. French.

PMID:
14598534
17.

Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.

Bandelow B, Wedekind D, Leon T.

Expert Rev Neurother. 2007 Jul;7(7):769-81. Review.

PMID:
17610384
18.

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.

Levitan MN, Papelbaum M, Nardi AE.

Neuropsychiatr Dis Treat. 2015 May 5;11:1149-55. doi: 10.2147/NDT.S67470. eCollection 2015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk